Related Experiment Videos
[Abnormalities of cellular immunity in uremic patients]
1Department of Internal Medicine, Tokai University, Kanagawa, Japan.
Nihon Jinzo Gakkai Shi
|June 1, 1993
Summary
Uremic patients undergoing hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD) exhibit altered T and B cell immune responses. These cellular immune abnormalities correlate with increased beta-2 microglobulin levels, impacting kidney failure patients.
Area of Science:
- Immunology
- Nephrology
- Cellular Biology
Context:
- Chronic renal failure (CRF) leads to significant immunological disturbances.
- Dialysis treatments, including hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD), are common for CRF patients.
- Understanding cellular immune function in uremia is crucial for managing patient health.
Purpose:
- To investigate cellular immune response abnormalities in patients with chronic renal failure undergoing dialysis.
- To analyze T cell subsets, B cell counts, and immunoglobulin production in HD and CAPD patients compared to healthy controls.
- To explore correlations between immunological parameters and serum beta-2 microglobulin (β2MG) levels.
Summary:
- Patients on HD and CAPD showed a higher CD4/CD8 ratio and increased activated T cells (DR+, IL-2R+) compared to controls.
- Activated T cell markers positively correlated with serum β2MG levels in dialysis patients.
- Reduced B cell counts (CD19+) and altered spontaneous immunoglobulin production were observed in uremic patients.
- Spontaneous immunoglobulin production was highest in HD patients, followed by CAPD patients and controls.
Impact:
- Altered T and B cell function likely contributes to the immunological abnormalities seen in chronic kidney disease patients on dialysis.
- Findings highlight the complex interplay between uremia, dialysis modality, and immune system dysfunction.
- This research provides insights into immune dysregulation in end-stage renal disease, potentially informing future therapeutic strategies.